相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Carbonic Anhydrase IX Controls Vulnerability to Ferroptosis in Gefitinib-Resistant Lung Cancer
Chen Zhang et al.
Oxidative Medicine and Cellular Longevity (2023)
Carbonic Anhydrase IX Suppression Shifts Partial Response to Checkpoint Inhibitors into Complete Tumor Eradication: Model-Based Investigation
Julia Grajek et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
A Carbonic Anhydrase IX/SLC1A5 Axis Regulates Glutamine Metabolism Dependent Ferroptosis in Hypoxic Tumor Cells
Geetha Venkateswaran et al.
MOLECULAR CANCER THERAPEUTICS (2023)
CA9 knockdown enhanced ionizing radiation-induced ferroptosis and radiosensitivity of hypoxic glioma cells
Wenpeng Huang et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2023)
The CAIX inhibitor SLC-0111 exerts anti-cancer activity on gastric cancer cell lines and resensitizes resistant cells to 5-Fluorouracil, taxane-derived, and platinum-based drugs
Elena Andreucci et al.
CANCER LETTERS (2023)
Screening of key genes related to ferroptosis and a molecular interaction network analysis in colorectal cancer using machine learning and bioinformatics
Fengfu Xue et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2023)
Screening of key genes related to ferroptosis and a molecular interaction network analysis in colorectal cancer using machine learning and bioinformatics
Fengfu Xue et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2023)
An in silico model to study the impact of carbonic anhydrase IX expression on tumour growth and anti-PD-1 therapy
Julia Grajek et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2023)
Understanding Drug Sensitivity and Tackling Resistance in Cancer
Jeffrey W. Tyner et al.
CANCER RESEARCH (2022)
Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications
Brent R. Stockwell
CELL (2022)
Genome-wide synthetic lethal screen unveils novel CAIX-NFS1/xCT axis as a targetable vulnerability in hypoxic solid tumors
Shawn C. Chafe et al.
SCIENCE ADVANCES (2021)
Outlining the Complex Pathway of Mammalian Fe-S Cluster Biogenesis
Nunziata Maio et al.
TRENDS IN BIOCHEMICAL SCIENCES (2020)
A Phase 1 Study of SLC-0111, a Novel Inhibitor of Carbonic Anhydrase IX, in Patients With Advanced Solid Tumors
Paul C. McDonald et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2020)
Persistent Cancer Cells: The Deadly Survivors
Shensi Shen et al.
CELL (2020)
The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond
Silvia Pastorekova et al.
CANCER AND METASTASIS REVIEWS (2019)
Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia
Paul C. McDonald et al.
GASTROENTEROLOGY (2019)
Targeting Hypoxia-Induced Carbonic Anhydrase IX Enhances Immune-Checkpoint Blockade Locally and Systemically
Shawn C. Chafe et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Harnessing Induced Essentiality: Targeting Carbonic Anhydrase IX and Angiogenesis Reduces Lung Metastasis of Triple Negative Breast Cancer Xenografts
Eva-Maria E. Hedlund et al.
CANCERS (2019)
Carbonic anhydrase 9 confers resistance to ferroptosis/apoptosis in malignant mesothelioma under hypoxia
Zan Li et al.
REDOX BIOLOGY (2019)
Discovery of 4-Hydroxy-3-(3-(phenylureido)benzenesulfonamides as SLC-0111 Analogues for the Treatment of Hypoxic Tumors Overexpressing Carbonic Anhydrase IX
Murat Bozdag et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: Three for the price of one
Claudiu T. Supuran et al.
MEDICINAL RESEARCH REVIEWS (2018)
Eco-evolutionary causes and consequences of temporal changes in intratumoural blood flow
Robert J. Gillies et al.
NATURE REVIEWS CANCER (2018)
Oxygen availability and metabolic reprogramming in cancer
Hong Xie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Biogenesis and functions of mammalian iron-sulfur proteins in the regulation of iron homeostasis and pivotal metabolic pathways
Tracey A. Rouault et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis
Samantha W. Alvarez et al.
NATURE (2017)
Synthetic lethality and cancer
Nigel J. O'Neil et al.
NATURE REVIEWS GENETICS (2017)
The interactome of metabolic enzyme carbonic anhydrase IX reveals novel roles in tumor cell migration and invadopodia/MMP14-mediated invasion
M. Swayampakula et al.
ONCOGENE (2017)
Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo
Nathaniel H. Boyd et al.
JCI INSIGHT (2017)
Tumour acidosis: from the passenger to the driver's seat
Cyril Corbet et al.
NATURE REVIEWS CANCER (2017)
Design and synthesis of a novel class of carbonic anhydrase-IX inhibitor 1-(3-(phenyl/4-fluorophenyl)-7-imino-3H-[1,2,3]triazolo[4,5d]pyrimidin 6(7H)yl)urea
Shikha Kumari et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2016)
Oxygen availability and metabolic adaptations
Michael S. Nakazawa et al.
NATURE REVIEWS CANCER (2016)
Carbonic Anhydrase IX Promotes Myeloid-Derived Suppressor Cell Mobilization and Establishment of a Metastatic Niche by Stimulating G-CSF Production
Shawn C. Chafe et al.
CANCER RESEARCH (2015)
Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
Rakesh K. Jain
CANCER CELL (2014)
Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche
F. E. Lock et al.
ONCOGENE (2013)
Disrupting proton dynamics and energy metabolism for cancer therapy
Scott K. Parks et al.
NATURE REVIEWS CANCER (2013)
Carbonic Anhydrase IX Promotes Tumor Growth and Necrosis In Vivo and Inhibition Enhances Anti-VEGF Therapy
Alan McIntyre et al.
CLINICAL CANCER RESEARCH (2012)
Recent Developments in Targeting Carbonic Anhydrase IX for Cancer Therapeutics
Paul C. McDonald et al.
ONCOTARGET (2012)
Targeting Tumor Hypoxia: Suppression of Breast Tumor Growth and Metastasis by Novel Carbonic Anhydrase IX Inhibitors
Yuanmei Lou et al.
CANCER RESEARCH (2011)
Ureido-Substituted Benzenesulfonamides Potently Inhibit Carbonic Anhydrase IX and Show Antimetastatic Activity in a Model of Breast Cancer Metastasis
Fabio Pacchiano et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Interfering with pH regulation in tumours as a therapeutic strategy
Dario Neri et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer
M. Ilie et al.
BRITISH JOURNAL OF CANCER (2010)
The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy
E. Y. Tan et al.
BRITISH JOURNAL OF CANCER (2009)
Expression of carbonic anhydrase IX suggests poor outcome in rectal cancer
E. Korkeila et al.
BRITISH JOURNAL OF CANCER (2009)
Carbonic Anhydrase IX in Bladder Cancer A Diagnostic, Prognostic, and Therapeutic Molecular Marker
Tobias Klatte et al.
CANCER (2009)
Hypoxia-Inducible Carbonic Anhydrase IX and XII Promote Tumor Cell Growth by Counteracting Acidosis through the Regulation of the Intracellular pH
Johanna Chiche et al.
CANCER RESEARCH (2009)
Role of carbonic anhydrase IX expression in prediction of the efficacy and outcome of primary epirubicin/tamoxifen therapy for breast cancer
Daniele Generali et al.
ENDOCRINE-RELATED CANCER (2006)
Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma
SK Chia et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)